Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.095 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |